Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Flaum Eye Institute at the University of Rochester Medical Center
601 Elmwood AvenueRochester, New York, United Kingdom
Phone Web
Multidisciplinary collaborations are a key to the successful enhancement of eye health. The University of Rochester Medical Center and the Flaum Eye Institute (FEI) provide an ideal environment for this work. One example of current multidisciplinary investigations is the Graves’ disease collaboration between Steven E. Feldon, an orbital disease specialist, and Richard Phipps, a researcher who specializes in the study of the biology of fibroblasts (connective tissue cells involved in thyroid eye disease).
Our team of physicians and researchers make the Flaum Eye Institute at the University of Rochester the region’s leader in specialty eye care. Our doctors are pioneering new diagnostics and treatments to help preserve vision. Often, clinical trials and new treatments are tested at the Flaum Eye Institute first. As the only eye institute in the region, we are committed to providing state-of-the-art eye care for common and complex vision problems right in Upstate New York.
Deficits to visual function may be caused by disease (such as orbital tumors or Graves’ disease), trauma (fractures) functional defects affecting alignment (strabismus/nystagmus), problems with the lacrimal system (tear glands) or aging (drooping eyelids). Surgical expertise at FEI includes treatment of orbital tumors, socket reconstruction, eyelid repair, and orbital decompression, as well as correction of paralytic strabismus and medically necessitated botox for blepharospasm.
myBinderRelated Content
-
The New England Journal of Medicine Publishes Comprehensive Data From Phase 3 Clinical Trial (OPTIC) of TEPEZZA™ (...Horizon Therapeutics plc announced that ...
-
Teprotumumab, an Insulin-Like Growth Factor-1 Receptor Antagonist Antibody, in the Treatment of Active Thyroid eye D...Thyroid eye disease is a disabling autoi...
-
Update on Graves’ Disease: Advances in Treatment of Mild, Moderate and Severe Thyroid Eye DiseasePurpose of Review: To report the most r...
-
Risk Factors For Developing Thyroid-Associated Ophthalmopathy Among Individuals with Graves’ DiseaseImportance: Thyroid-associated ophthalm...
-
William R. Katowitz, MDWilliam R. Katowitz is an attending surg...
-
TEPEZZA (teprotumumab-trbw)- Frequently Asked Questions1. What is TEPEZZA? TEPEZZA is the firs...
-
Thyroid Eye Disease – University Hospitals Sussex NHS Foundation Trusthttps://www.youtube.com/watch?v=bp2ruwWS...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Facebook
Google